WASHINGTON--In its first foray into the area since the 2000 elections, the House Committee on Government Reform will hold a hearing March 20 addressing the Food and Drug Administration's (FDA) policies relating to dietary supplements. Beth Clay, professional staff member with the committee, confirmed the hearing is scheduled, but that further details are still preliminary.
According to Clay, the committee, which is chaired by Rep. Dan Burton (R-Ind.), will address issues including pending action on ephedra, status of federal good manufacturing practices (GMPs) and issues with Codex. "With the change in political power in Washington, this was a good time to address these issues," Clay noted. An update on the hearing from the National Nutritional Foods Association (NNFA) noted that David Seckman, NNFA executive director, will testify at the hearing about NNFA's GMP program, while Karl Riedel, an NNFA board member, will testify about Codex.
The hearing will take place during NNFA's annual lobbying day in Washington. It follows a one-day conference set for March 19 titled "Targeting the Questions of Quality." For information on the conference or lobbying day, visit www.nnfa.org/legislative/evite.htm.
Email this article
Add a comment
Printer version
Order reprints
RSS Feed
Bookmark article